AFC revenue tripled to NZ$1.1m but H2 reversed and cash hit NZ$5,000

Operating cash flow flipped positive at NZ$0.1m from an NZ$0.1m outflow. On the surface this is a recovery story, but the half-on-half shape inside FY23 tells a different one.

Comparing FY23 to HY23, the second half deteriorated materially: implied H2 revenue was NZ$0.4m versus NZ$0.7m in the first half, and implied H2 NPAT was a NZ$0.1m loss versus only a NZ$15,000 loss in H1. Roughly 62.4% of full-year revenue, and almost 90% of the full-year loss, came in different halves.

Balance sheet pressure intensified. Cash fell to NZ$5,000 from NZ$14,000, gross borrowings rose 56.6% to NZ$0.1m, and total equity contracted 32.4% to NZ$0.4m.

Annualising the implied H2 (NZ$0.4m revenue, NZ$0.1m loss) produces a very different trajectory from the FY23 print. The 159.0% growth claim therefore sets a misleading anchor for FY24 unless the H2 softness is explained as one-off rather than a step down in demand.

Liquidity is the most material economic issue, not the narrower loss. Closing cash of NZ$5,000 against NZ$0.1m of gross borrowings and an NZ$0.1m H2 loss leaves essentially no operating buffer. Equity has eroded from NZ$0.6m to NZ$0.4m and ROE remains deeply negative at -38.8% (prior -71.8%). At this scale, the funding question dominates the earnings recovery.

Operating cash flow turned positive but for non-durable reasons. Inventories fell from NZ$0.4m to NZ$0.3m, and operating working capital declined by roughly NZ$0.1m. The OCF inflow of NZ$0.1m is broadly the same order as that working-capital release, which means the positive cash result is largely a balance-sheet drawdown rather than profit conversion. FCF/NPAT of -40.7% confirms cash generation is not yet aligned with earnings.

The shape data also offers no support for a second-half-weighted seasonal pattern; on the supplied figures the second half was weaker, not stronger.

What the release does support is that AFC ended FY23 with materially less liquidity than it began, equity continuing to erode, and an H2 run-rate below H1. What it does not support is any claim that the trajectory implied by full-year revenue growth is the right base for FY24. That gap matters because at this cash position even a modest continuation of H2 losses would require new funding.

The narrower NPAT loss is partly mechanical: revenue scaled from a very low FY22 base of NZ$0.4m, while gross borrowings rose and equity fell. Capex was negligible at 0.3% of revenue, so the company is not investing meaningfully into the growth it is reporting.

The cash result is the clearest quality issue. Operating cash inflow of NZ$0.1m coincides with an NZ$37,000 inventory reduction and broader working-capital release of roughly NZ$0.1m. That implies the cash turn is timing- and balance-sheet-driven rather than earnings-driven, which matters because there is limited inventory left to release a second time. Combined with the H2 revenue and NPAT step-down, the durable read on FY23 is closer to the H2 shape than to the full-year headline.

This briefing cannot assess going-concern status or any post-balance-date funding arrangements, because the supplied disclosures do not contain that information and the FY22 comparable was inferred rather than confirmed.